Table 1 Baseline characteristics and perioperative outcomes of 95 patients with stage 0-III rectal cancer undergoing robotic-assisted total mesorectal excision
Characteristic | |
|---|---|
Age (years, median) (range) | 62 (28–88) |
Gender | |
 Female | 35 (36.8%) |
 Male | 60 (63.2%) |
Tumor distance from anal verge (cm) | |
 ≦ 5 (Lower) | 48 (50.5%) |
 6–10 (Middle) | 30 (31.6%) |
 11–15 (Upper) | 17 (17.9%) |
Distance from anal verge (cm, median) (range) | 5.5 (1–15) |
Pre-operation CCRT | |
 Yes | 75 (78.9%) |
 No | 20 (21.1%) |
Pre-operation chemotherapy regimen | 75 |
 FOLFOX | 58 (77.3%) |
 Fluoropyrimidine-based | 17 (22.7%) |
Time interval between radiotherapy completion and robotic surgery (day, median) (range) (75 patients undergoing pre-operation chemotherapy) | 82 (41–203) |
ASA classification | |
 II | 52 (54.7%) |
 III | 43 (45.3%) |
BMI kg/m2 (Median) (range) | 23.54 (17.20–34.02) |
Procedure | |
 LAR | 59 (62.1%) |
 ISR | 32 (33.7%) (including 3 transabdominal ISR) |
 APR | 4 (4.2%) |
Protective Diverting Colostomy | |
 Yes | 38 (40.0%) |
 No | 57 (60.0%) |
Docking Time (min, median) (range) | 5 (3–22) |
Console Time (min, median) (range) | 200 (130–435) |
Operation Time (min, median) (range) | 325 (210–795) |
Estimated blood loss (mL, Median) | 80 (15–1050) |
Time of first flatus passage (day) (Median, range) | 2 (1–10) |
Time of resuming soft diet (day) (Median, range) | 4 (2–15) |
Postoperative hospital stay (day) (Median, range) | 6 (5–32) |
Postoperative first day VAS pain score (Median, range) | 3 (1–8) |